Showing results (511-520 of 1,408) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|April 10, 2026
Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein diseaseAlena M Smith, Sara A Lorkiewicz, Burak Arslan, et al.NPJ Parkinson'S Disease|April 14, 2026
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's diseaseAndrea Mastrangelo, Isabel Wurster, Alice Ticca, et al.NPJ Parkinson'S Disease|April 14, 2026
Novel associations of VPS13C with phenotype and conversion of idiopathic REM sleep behavior disorderYanfei Ding, Xinyi Zhou, Aonan Zhao, et al.NPJ Parkinson'S Disease|April 27, 2026
Frequency-based deep learning to identify subtle postural instability in early, untreated Parkinson's diseaseDavid Engel, Pablo Burgos, Patricia Carlson-Kuhta, et al.NPJ Parkinson'S Disease|May 8, 2026
Identifying maximal beta power from directional subthalamic local field potentials in Parkinson's diseaseJennifer K Behnke, Robert L Peach, Moritz Gerster, et al.NPJ Parkinson'S Disease|April 11, 2026
Pathology-Anchored Transcranial Sonography: A Cascaded Super-Resolution Deep Learning System for Early-Stage Parkinson's Disease GradingYishen Zhao, Weiguo Cui, Shuang Liang, et al.NPJ Parkinson'S Disease|April 25, 2026
Plasma proteomics for Parkinson's disease classification: cross-cohort benchmarking of proteomic, transcriptomic, and multimodal modelsNicholas Minster, Saleet JafriNPJ Parkinson'S Disease|April 15, 2026
Tissue-specific mutation of pink-1 jointly induces intestinal dysfunction and contributes to dopaminergic neuron degenerationHuan Gu, Yixin Li, Guolin Shi, et al.NPJ Parkinson'S Disease|May 6, 2026
The epitranscriptomic m6A RNA modification modulates the synapse in ageing and in a mouse model of synucleinopathyAvika Chopra, Mary Xylaki, Fanzheng Yin, et al.NPJ Parkinson'S Disease|May 6, 2026
Matters arising: critical appraisal of device aided therapy outcomes in Parkinson's diseaseQingliu Zheng, Changyun LiuPageof 141